158 related articles for article (PubMed ID: 10699953)
1. Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A.
Ciardiello F; Caputo R; Pomatico G; De Laurentiis M; De Placido S; Bianco AR; Tortora G
Int J Cancer; 2000 Mar; 85(5):710-5. PubMed ID: 10699953
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
Tortora G; Ciardiello F; Damiano V; Pepe S; Bianco C; di Isernia G; Davies SL; North P; Harris AL; Hickson ID
Clin Cancer Res; 1995 Jan; 1(1):49-56. PubMed ID: 9815886
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 proto-oncogenes.
Ciardiello F; Pepe S; Bianco C; Baldassarre G; Ruggiero A; Bianco C; Selvam MP; Bianco AR; Tortora G
Int J Cancer; 1993 Feb; 53(3):438-43. PubMed ID: 8094073
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits.
Tagliaferri P; Tortora G; Guarrasi R; Damiano V; Ruggiero A; Morelli D; Caraglia M; Bianco R; di Isernia G; Pepe S; Arteaga CL; Langton-Webster BC; Bianco AR; Ciardiello F
Clin Cancer Res; 1996 Jan; 2(1):207-14. PubMed ID: 9816108
[TBL] [Abstract][Full Text] [Related]
5. Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells.
Ciardiello F; Gottardis M; Basolo F; Pepe S; Normanno N; Dickson RB; Bianco AR; Salomon DS
Mol Carcinog; 1992; 6(1):43-52. PubMed ID: 1354442
[TBL] [Abstract][Full Text] [Related]
6. Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells.
Normanno N; Selvam MP; Qi CF; Saeki T; Johnson G; Kim N; Ciardiello F; Shoyab M; Plowman G; Brandt R
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2790-4. PubMed ID: 7908443
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
8. Regulation of heparin-binding EGF-like growth factor expression in Ha-ras transformed human mammary epithelial cells.
MartÃnez-Lacaci I; De Santis M; Kannan S; Bianco C; Kim N; Wallace-Jones B; Wechselberger C; Ebert AD; Salomon DS
J Cell Physiol; 2001 Feb; 186(2):233-42. PubMed ID: 11169460
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.
Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; De Placido S; Bianco AR; Tortora G
Clin Cancer Res; 2000 May; 6(5):2053-63. PubMed ID: 10815932
[TBL] [Abstract][Full Text] [Related]
10. Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer.
Hengstler JG; Lange J; Kett A; Dornhöfer N; Meinert R; Arand M; Knapstein PG; Becker R; Oesch F; Tanner B
Cancer Res; 1999 Jul; 59(13):3206-14. PubMed ID: 10397267
[TBL] [Abstract][Full Text] [Related]
11. ZD1839 (IRESSA), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrug-resistant MCF-7 ADR human breast cancer cells.
Ciardiello F; Caputo R; Borriello G; Del Bufalo D; Biroccio A; Zupi G; Bianco AR; Tortora G
Int J Cancer; 2002 Mar; 98(3):463-9. PubMed ID: 11920601
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
Kelland LR; Abel G
Cancer Chemother Pharmacol; 1992; 30(6):444-50. PubMed ID: 1356649
[TBL] [Abstract][Full Text] [Related]
13. Decreased response to paclitaxel versus docetaxel in HER-2/neu transfected human breast cancer cells.
Witters LM; Santala SM; Engle L; Chinchilli V; Lipton A
Am J Clin Oncol; 2003 Feb; 26(1):50-4. PubMed ID: 12576925
[TBL] [Abstract][Full Text] [Related]
14. In vitro comparative evaluation of trastuzumab (Herceptin) combined with paclitaxel (Taxol) or docetaxel (Taxotere) in HER2-expressing human breast cancer cell lines.
Merlin JL; Barberi-Heyob M; Bachmann N
Ann Oncol; 2002 Nov; 13(11):1743-8. PubMed ID: 12419746
[TBL] [Abstract][Full Text] [Related]
15. Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast cancer cell growth.
Tortora G; Caputo R; Pomatico G; Pepe S; Bianco AR; Agrawal S; Mendelsohn J; Ciardiello F
Clin Cancer Res; 1999 Apr; 5(4):875-81. PubMed ID: 10213224
[TBL] [Abstract][Full Text] [Related]
16. erbB-2 overexpression in human mammary epithelial cells confers growth factor independence.
Ignatoski KM; Lapointe AJ; Radany EH; Ethier SP
Endocrinology; 1999 Aug; 140(8):3615-22. PubMed ID: 10433219
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A.
Tortora G; Caputo R; Damiano V; Bianco R; Pepe S; Bianco AR; Jiang Z; Agrawal S; Ciardiello F
Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12586-91. PubMed ID: 9356493
[TBL] [Abstract][Full Text] [Related]
18. The RI alpha subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells.
Tortora G; Pepe S; Bianco C; Baldassarre G; Budillon A; Clair T; Cho-Chung YS; Bianco AR; Ciardiello F
Oncogene; 1994 Nov; 9(11):3233-40. PubMed ID: 7936647
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity.
Tortora G; Caputo R; Damiano V; Fontanini G; Melisi D; Veneziani BM; Zunino F; Bianco AR; Ciardiello F
Clin Cancer Res; 2001 Dec; 7(12):4156-63. PubMed ID: 11751516
[TBL] [Abstract][Full Text] [Related]
20. Effects of tubulin-inhibiting agents in human lung and breast cancer cell lines with different multidrug resistance phenotypes.
van Ark-Otte J; Samelis G; Rubio G; Lopez Saez JB; Pinedo HM; Giaccone G
Oncol Rep; 1998; 5(1):249-55. PubMed ID: 9458331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]